Percutaneous core-needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas

J Demharter1, P Müller, T Wagner

  • 1Department of Radiology, Zentralklinikum Augsburg, Germany.

European Radiology
|February 24, 2001
PubMed

Insights

Percutaneous core-needle biopsy accurately diagnoses malignant lymphomas with high sensitivity and specificity. This image-guided method is effective for both initial diagnosis and subclassification of these cancers.

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Malignant lymphomas require accurate diagnosis and subclassification for effective treatment.
  • Percutaneous biopsy is a minimally invasive technique for tissue sampling.

Purpose of the Study:

  • To assess the diagnostic accuracy (sensitivity and specificity) of image-guided percutaneous core-needle biopsy for malignant lymphomas.
  • To evaluate the utility of this method in subclassifying lymphomas.

Main Methods:

  • 158 image-guided percutaneous core-needle biopsies of enlarged lymph nodes were performed using a Tru-cut needle.
  • Biopsy findings were confirmed by histology or clinical/radiologic correlation in 135 cases.

Main Results:

  • The biopsy demonstrated 89% sensitivity and 97% specificity for diagnosing malignant lymphomas.
  • Of correctly diagnosed lymphomas, 95% could be subclassified using core-needle biopsy.
  • The method correctly identified malignant lymphomas, nodal metastases, and benign conditions.

Conclusions:

  • Image-guided percutaneous core-needle biopsy is a valuable tool for diagnosing and subclassifying malignant lymphomas.
  • The Tru-cut needle biopsy offers high diagnostic accuracy for nodal lesions.

Related Concept Videos